U.S. Sens. Smith, Durbin, Cramer, Cassidy’s Call to FDA: Price of Insulin is “Unacceptable” and Action is Needed to Bring Generics to Market
March 25, 2019
Senators Urge FDA to Revise Recent Policy Changes That Would Prevent Lower-Cost Insulin Products From Coming to Market WASHINGTON, D.C. [03/04/2019]—U.S. Senators Tina Smith (D-Minn.),
U.S. Sens. Tina Smith, Jerry Moran Reintroduce Bill to Make Life-saving Oral Cancer Medications More Affordable
March 25, 2019
Senators’ Reintroduce Legislation to Ensure Oral Cancer Drugs are Covered in Same Way as Traditional IV Chemotherapy WASHINGTON, D.C. [03/12/19]—Today, U.S. Sens. Tina Smith (D-Minn.)